Active substanceErythromycinErythromycin
Dosage form: & nbsptablets, coated with enteric film coating
Pharmacotherapeutic group:antibiotic-macrolide
ATX: & nbsp

S.01.A.A.17   Erythromycin

J.01.F.A.01   Erythromycin

Form release / dosage:Tablets, coated with enteric film coating, 500 mg.
Packaging:
  • (5) - Contour Cell Pack (1) / Instruction for medical use of the drug /
  • (5) - contour cell pack (2) / instruction for medical use of the drug /
  • (5) - Contour Cell Pack (3) / Instruction for medical use of the drug /
  • (5) - Contour Cell Pack (4) / Instruction for medical use of the drug /
  • (5) - Contour Cell Pack (5) / Instruction for medical use of the drug /
  • (5) - Contouring Cell Pack (6) / Instruction for medical use of the drug /
Storage conditions:In a dry, dark place, at a temperature of no higher than 25 FROM.
Keep out of the reach of children.
Shelf life:3 years.
Terms of leave from pharmacies:On prescription
Registration number:LC-002411
Date of registration:27.07.2011
The owner of the registration certificate:SYNTHESIS, JSC Joint-stock Kurgan Society of Medical Preparations and Products SYNTHESIS, JSC Joint-stock Kurgan Society of Medical Preparations and Products Russia
Manufacturer: & nbsp
Representation: & nbspSYNTHESIS JSC Joint-Stock Kurgan Society of Medical Preparations and Products SYNTHESIS JSC Joint-Stock Kurgan Society of Medical Preparations and Products Russia
Information update date: & nbsp29.09.2015
Illustrated instructions
    Instructions
    Up